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Coronaviruses are a large group of viruses known to 
cause mild to severe acute respiratory illnesses (SARs) 
in humans. The particular virus that is the cause of the 
2019-2020 novel Coronavirus outbreak is the SARS-
CoV-2 virus, which results in the COVID-19 illness 
and is the cause of the COVID-19 global pandemic. 
[SARS-CoV-2 is technically the virus, and COVID-19 is 
the illness; the terms are often used interchangeably]. 
Coronavirus is most often transmitted through vi-
ral shedding, where the virus is transmitted from one 
individual to another (community transfer) or through 
environmental contamination. Viruses are not “alive” 
as bacteria are. They are referred to as virions or “viral 
particles” and are essentially nucleic acid (RNA or 
DNA) surrounded by a protein-lipid-membrane coat, 
which infects a mammalian host cell and commandeers 
the biochemical machinery of that cell to produce the 
components to make new virions. There has been 
much speculation about possible animal origins of 
SARS-CoV-2 given that the RNA shows some similar-
ity to SARS-CoV-1 (80% similarity) and an even higher 
similarity to SARS-CoV virus isolated from pangolin 
(91%) and bats (96%) [1].
Coronavirus-2 (SARS-CoV-2, COVID-19) is an RNA 
virus surrounded by a coat that has prominent “spike 
proteins” protruding from its surface. These spike pro-
teins (glycoproteins) are the main molecule that initiates 
attachment to receptors on human cells. Its genome 
consists of single stranded RNA that is complexed with 
nucleocapsid protein (N protein), which helps with RNA 
folding. Envelope (E) protein and membrane protein 
(M) form the bulk of the remaining capsid shell proteins 
and assist with the fusion of host and viral membranes 
required for host infection. 
The receptor on human host cells for the SARS-
CoV-2 virus is a transmembrane protein, ACE2 (i.e., 
angiotensin converting enzyme 2). The human ACE2 
receptor proteins are on the surface of many types of 
human cells including the epithelial lining of the lung, 
intestine, liver, kidney, heart and other tissues. The 
ACE2 receptor serves as the main binding receptor 
for the viral spike protein and helps mediate entry into 
human cells that end up serving as host cells for viral 
replication. Receptors often extend through a cell mem-
brane (i.e., transmembrane), whereby binding externally 
at the receptor initiates biochemical activity at the other 
end of the molecule inside the cell. Several other host 
transmembrane enzyme proteins (proteases) also 
participate during infection (TMPRSS2, CTSL) in which 
there is a dual binding activation, first ACE2 binding to 
Spike protein and then binding and proteolytic activity of 
Spike by TMPRSS2 (or CTSL). Binding of the viral spike 
protein to the host membrane ACE2 receptor is the initial 
binding event and is further assisted by a proteolytic 
membrane protein (TMPRSS2). The result of this “tag 
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team” receptor action at the cell membrane results in 
the virus coat membrane fusing with the human host 
cell membrane. This releases the virus genome (RNA) 
into the host cell cytoplasm, taking over the host cells’ 
biochemical machinery to direct assembly and packag-
ing of new viral particles that are released by “budding.”
Although receptors for the SARS-CoV-2 virus are 
found in the lung, intestine, liver, kidney, heart and other 
tissues, it is commonly recognized the primary site of 
human infection is in the lung. One study has shown 
children do not yet have high level expression of ACE2 
in their lungs, and this may explain why they are not 
infected as readily as adults. Infection of the intestinal 
tract epithelium because of ACE2 receptors found there 
may explain why a high proportion of patients experi-
ence diarrhea as one of their symptoms, although there 
have been disputed claims of whether active virus, or 
simply the SARS-CoV-19 RNA, has been isolated from 
feces. The isolation of active virus from feces would be 
significant because of the potential for hand-to-mouth 
spread if sanitary practices are not strictly adhered to 
after such diarrheal episodes. A recent article discussed 
the potential for “toilet spray” aerosolization from flushing 
of diarrheal episodes resulting in 40-60% of aerosolized 
viruses rising above the toilet seat [2]. Further, wide-
spread dissemination could occur if sewage treatment 
centers are overwhelmed with excess rainstorm runoff 
water and subsequently release untreated sewage that 
could contain active virus particles. This is the reason 
health departments of coastal towns examine water 
for contamination by “fecal coliforms” to determine the 
quality of water for bathers and the suitability of water 
quality for shellfish harvesting from shoreline clam beds. 
The COVID-19 pandemic has broadened the potential 
for examining sewage treatment water, not only for bac-
terial pathogens but also for use as an epidemiological 
barometer of the extent of viral presence in a community 
served by the treatment facility [3].
Experts at CDC believe the majority of SARS-
CoV-2 infections are spread and acquired through 
respiratory droplets, whereby the virus is aerosolized 
upon sneezing, coughing and even by simply talking or 
breathing. Violent sneezes have been shown to gener-
ate aerosolized droplets that can travel as far as 23-27 
feet and further, depending on the size of the particle 
[4,5]. Small aerosolized droplets can stay suspended 
without evaporating for longer periods in humid climates. 
The distance aerosolized particles can travel from a 
cough or sneeze is significant given the number of viral 
particles that could be present in sputum or nasal dis-
charge. Quantitative analysis of viral loads found levels 
of approximately 2-8 log10 (10
2-108) viral particles per ml 
(depending on the virus examined) of sputum, which 
demonstrated higher viral loads than swabs dunked 
in sputum (“dunked sputum”) or from nose and throat 
swabs (NTS). Other studies quantifying RNA have 
shown high levels in sputum (106-1011 RNA/ml) vs nasal 
(106-109 RNA/swab) or throat (106-109 RNA/swab) swabs 
[6]. It is easy to speculate if billions of viral particles 
are generated by a single infected person/animal, low 
incidence mutational changes in the RNA genome that 
reflect the amino acids of the receptor binding domain, 
can result in a sequence that is even better suited to 
binding a specific type of host cell. This would make for 
a greater likelihood of infectivity or can even change the 
specificity to a different species.
The manner in which new virus particles are re-
leased is not like the “burst size” of lytic bacteriophage, 
which are released from infected bacteria by lysing or 
“bursting” out from the host cell and killing them. Newly 
formed COVID-19 virus particles are released from in-
fected cells by continuously “budding” new virions from 
the surface of infected host cells without killing them. 
Based on tissue culture cell analysis, it takes about 10 
minutes to infect a host cell, around 10 hours to generate 
a new virion particle, and each host cell can release as 
many as 1,000 virus particles over the duration of the 
infection [7]. This explains why sputum and nasal dis-
charge have such high levels of virus particles and even 
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the gentle exhale during talking can create aerosolized 
droplets containing COVID-19 virus. A more violent dis-
charge (sneeze, cough) can create an array of droplets 
of different sizes, and smaller ones can travel further via 
air currents before landing on surfaces or being inhaled 
by other humans. Investigations in two hospitals in 
Wuhan, China, found infectious COVID-19 RNA in the 
air in as small as sub-micron droplet size and initiated 
a program to disinfect the air where COVID-19 patients 
had been [8]. The COVID-19 virus can remain infectious 
for numerous hours after settling on various surfaces 
and the ability to infect has been examined 
in reference to “half-life” of infectivity. Large 
scale, area-wide fogging systems to perme-
ate entire rooms have been used to disinfect 
hospital rooms that once held Coronavirus 
patients, and high-intensity ultraviolet light 
systems have been installed in ductwork to 
sanitize aerosolized virus particles carried 
in the air distributed by ventilation systems.
Once infected, it takes about 3 days 
for a person to become infectious (i.e., 
“latent period”) and then that person will be 
infectious for about 4 days before showing 
symptoms. It is during this asymptomatic 
infectious period where an infected person 
can be infecting other people if there are 
no distancing or if mask wearing practices 
are not adopted. Infectivity and spread of 
infection often are referred to by the “effec-
tive reproduction number” (R0, “R naught” 
or “R zero”). An R0 = 1 indicates for every 1 
person infected, it is transmitted to 1 other 
person. An R0<1 suggests spreading can be controlled; 
an R0>1 indicates spreading of an infection among the 
population. With an R0=4, it is expected the number 
of cases will approximately double every ~3 days and 
quadruple every ~7 days. The latency and infectious 
period can be variable; an epidemiological analysis of 
the outbreak in Wuhan, China, suggests the latency 
incubation period was 5.1 days and 97.5% of those that 
developed symptoms did so within 11.5 days and 1% 
of the cases did not show symptoms until 14 days. So, 
the longer the infectious period is maintained without 
symptoms, the greater the 
number of people who can 
become infected, especially 
when there are no counter-
measures (masks, distanc-
ing) being practiced. This 
is where testing and avail-
ability of test results can 
help by identifying who is 
infected (and not yet show-
ing symptoms), so they may 
be quarantined instead of 
contributing more to the 
spread of the virus. 
There has been much 
discussion about infectiv-
ity by virus particles left 
behind on various types 
of surfaces (door knobs, 
tables, desks, packages in 
supermarket, push buttons, 
cell phones, etc.) and stud-
ies have shown COVID-19 
virus may last for some lim-
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ited time on such surfaces. Since viruses are not “alive,” 
the timeframe of their infectivity has more to do with 
denaturation of the outer protein/coat components, so 
they cannot interact with their human host cell receptors 
and possible irreversible binding of the virus proteins to 
surfaces. The “decay” of infective titers of SARS-CoV-1 
vs. SARS-CoV-2 have been compared on various sur-
faces and have shown titers diminish greatest on copper 
and slowest on plastic surfaces (copper > cardboard 
> stainless steel > plastic). Also, the infectivity of virus 
particles can persist for hours when aerosolized [9].
The potential infectiveness of airborne/aerosolized 
COVID-19 particles underlies the importance of wear-
ing masks to prevent widespread expulsion of virus 
particles by infected asymptomatic, presymptomatic or 
weakly symptomatic people, or inhalation uptake by yet 
uninfected people. In certain parts of the world, people 
are more accustomed to using face masks, if not for 
protection from infectious disease, then often because of 
widespread air pollution. People in Western nations are 
not as accustomed to wearing masks as those in some 
Asian nations, and this may have resulted in holding the 
spread of virus in check or at least providing a lower 
trajectory of increase in the number of cases among 
those cultures. The importance of wearing face masks 
is borne out in the most recent CDC recommendations. 
The intention of wearing masks and other preven-
tive measures (i.e., social distancing) is to reduce the 
spread of virus (i.e., R0 ≤ 1.0) so as not to overburden 
the healthcare system in regard to unrelenting burden on 
healthcare workers, their supply of personal protective 
equipment and availability of intensive care unit beds. 
Reducing the trajectory of an outbreak is often referred 
to as “flattening the curve.” Putting such measures into 
practice may not completely control the outbreak, but 
they can lessen the intensity of the virus burden on the 
healthcare system so it can better work with the cases 
of illness.
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